Singapore markets closed

Cyclerion Therapeutics, Inc. (CYCN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8807-0.0693 (-7.29%)
At close: 03:59PM EST
0.9100 +0.01 (+1.11%)
Pre-market: 08:00AM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
479
3,320
2,296
4,507
0
Operating expenses
Research development
37,501
37,636
56,414
95,140
87,716
Selling general and administrative
15,411
20,620
28,816
34,404
27,536
Total operating expenses
51,841
57,634
85,230
129,544
115,252
Operating income or loss
-51,362
-54,314
-82,934
-125,037
-115,252
Interest expense
-
16
-
-
-
Total other income/expenses net
-
2,683
4,544
-
-
Income before tax
-47,637
-51,647
-77,802
-123,008
-115,252
Income from continuing operations
-47,637
-51,647
-77,802
-123,008
-115,252
Net income
-47,637
-51,647
-77,802
-123,008
-115,252
Net income available to common shareholders
-47,637
-51,647
-77,802
-123,008
-115,561
Basic EPS
-
-1.32
-2.56
-4.49
-4.22
Diluted EPS
-
-1.32
-2.56
-4.49
-4.22
Basic average shares
-
39,144
30,403
27,380
27,304
Diluted average shares
-
39,144
30,403
27,380
27,304
EBITDA
-
-51,159
-80,637
-122,337
-113,724